<DOC>
	<DOCNO>NCT02954003</DOCNO>
	<brief_summary>The purpose study collect clinical data support use ValenTx Endo Bypass System improve weight loss resolution comorbidities obese subject .</brief_summary>
	<brief_title>The ValenTx Endo Bypass System Obese Subjects</brief_title>
	<detailed_description>- Single-arm , non-randomized , open-label , multi-center trial conduct 70 subject assess safety efficacy ValenTx Endo Bypass System implant duration 36 month . - Body weight , adverse event device function implant subject monitor monthly visit first year implant , quarterly visit second year , biannually third year . - Additional follow-up data include vital sign , hip waist circumference , blood lab test , endoscopic assessment condition implant device , quality life questionnaire . - All subject follow 12 month device removal schedule visit 1 , 6 12 month explant . - Subject participation may last four year , expect vary implant duration , determine case-by-case basis base condition implant device .</detailed_description>
	<criteria>Inclusion Criteria 1 . Between 18 60 year old . 2 . BMI 4050 kg/m2 without comorbidities , BMI 3540 kg/m2 one obesity relate comorbidities , BMI 3035 type 2 diabetes 3 . Willing give inform consent , able understand mean . 4 . Documented failure nonsurgical weight loss method . 5 . Willing follow study procedure comply visit schedule . 6 . Live within reasonable distance research center able attend routine follow visit . Exclusion Criteria 1 . Pregnancy intention become pregnant course study . 2 . Abnormal screen esophagogastroduodenoscopy finding 3 . Prior esophageal , gastric bariatric surgery . 4 . Known allergy device material . 5 . Use weight loss drug , stimulant and/or herbal weight loss supplement . 6 . Recent ongoing health condition contraindicate undergoing elective weight loss procedure involve device implant within lumen esophagus , stomach proximal small intestine . 7 . Participation another clinical trial within 60 day implant . 8 . Presence psychiatric condition would impair ability provide inform consent comply study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Weight Loss</keyword>
</DOC>